|
January 5, 2012
Quanterix Announces Strategic Investment From IQT
December 22, 2011
Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems Based on Single Molecule Array Technology
December 1, 2011
Quanterix Receives Funding From the Department of Homeland Security to Develop Test for Botulinum Toxin
November 4, 2011
Fighting Breast Cancer Early, One Cell At A Time
November 2, 2011
Quanterix Fifth–Generation PSA Test Enables More Sensitive Measurements Following
October 13, 2011
Quanterix PSA Test Found to be a Reliable Predictor of Prostate Cancer Recurrence Following Surgery
September 19, 2011
Dr. Martin Madaus Joins Quanterix as CEO
August 19, 2011
Quanterix Digital ELISA Measures Low Abundance Biomarkers of Inflammation in Crohn’s Disease
August 16, 2011
Quanterix and STRATEC Announce Strategic Partnership
July 21, 2011
Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance
July 20, 2011
Quanterix and Sony DADC to Develop and Manufacture Smart Consumables for Life Science and In Vitro Diagnostic Applications
April 12, 2011
Quanterix Discovers Link Between Heart Attack–induced Hypoxia and Suspected Alzheimer’s Disease Pathway
February 23, 2011
Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability
February 22, 2011
Quanterix Announces New Technology Evaluation Agreement with Novartis
December 17, 2010
Quanterix CEO David Okrongly to Present at Biotech Showcase 2011
December 1, 2010
Dr. Martin Madaus Joins Quanterix Board of Directors
November 2, 2010
Quanterix Awarded $733,437 in Qualifying Therapeutic Discovery Project (QTDP) Grants
September 29, 2010
Novel Test Following Prostate Surgery Could Detect Cancer Recurrence Earlier
May 23, 2010
Groundbreaking Study Published in Nature Biotechnology Demonstrates Sensitivity of Single Molecule Test for Detection of Prostate Cancer
September 2, 2009
Quanterix Corporation Announces the Appointment of Dr. David Okrongly to CEO
November 11, 2008
Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
September 30, 2008
<
Quanterix Corporation Awarded $185,000 Grant from the National Cancer Institute
August 25, 2008
Quanterix Corporation Raises $15 Million in Series A Financing
|
